US Patent 7479261 Method of separating and purifying Cesium-131 from Barium nitrate
Patent 7479261 was granted and assigned to Isoray Medical, Inc. on January, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Garrett N Brown0
Lane Allan Bray0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+312 characters)
Article
Patent abstract
The present invention provides a method of separating and purifying Cesium-131 (Cs-131) from Barium (Ba). Uses of the Cs-131 purified by the method include cancer research and treatment, such as for the use in brachytherapy. Cs-131 is particularly useful in the treatment of faster growing tumors.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07479261 Method of separating and purifying Cesium-131 from Barium nitrate US Patent 7479261 Method of separating and purifying Cesium-131 from Barium nitrate
Infobox
Patent Number
074792610
Patent Number
74792610
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074792610
Date of Patent
January 20, 2009
0Patent Application Number
111588990
Date Filed
June 22, 2005
0Official Website
Patent Primary Examiner
Edits on 14 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 1 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07479261 Method of separating and purifying Cesium-131 from Barium nitrate
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07479261
Date of patent
January 20, 2009
Patent application number
11158899
Date Filed
June 22, 2005
Patent primary examiner
Find more entities like US Patent 7479261 Method of separating and purifying Cesium-131 from Barium nitrate
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
